These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19596975)

  • 1. Phase II study of weekly paclitaxel as a second-line treatment for S-1-refractory advanced gastric cancer.
    Matsuda G; Kunisaki C; Makino H; Fukahori M; Kimura J; Sato T; Oshima T; Nagano Y; Fuii S; Takagawa R; Kosaka T; Ono HA; Akiyama H; Ichikawa Y
    Anticancer Res; 2009 Jul; 29(7):2863-7. PubMed ID: 19596975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
    Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
    Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric Cancer (CCOG0302 study).
    Kodera Y; Ito S; Mochizuki Y; Fujitake S; Koshikawa K; Kanyama Y; Matsui T; Kojima H; Takase T; Ohashi N; Fujiwara M; Sakamoto J; Akimasa N;
    Anticancer Res; 2007; 27(4C):2667-71. PubMed ID: 17695430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Feasibility study of weekly paclitaxel as second-line chemotherapy against 5-FU-refractory gastric carcinoma].
    Ito S; Kodera Y; Mochizuki Y; Yamamura Y
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1427-30. PubMed ID: 16227742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Weekly administration regimen of paclitaxel (PTX) in patient with inoperable or recurrent gastric cancer].
    Kii T; Takiuchi H; Gotoh M; Kawabe S; Ohta S; Tanaka T; Kuwakado S; Nishitani H; Katsu K
    Gan To Kagaku Ryoho; 2006 May; 33(5):621-4. PubMed ID: 16685160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of weekly administration of paclitaxel for advanced or recurrent gastric cancer].
    Egawa T; Kubota T; Nagashima A; Doi M; Kitano M; Hayashi S; Yoshii H; Saikawa Y; Kitajima M
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):877-81. PubMed ID: 15222104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
    Hatori S; Kunisaki C; Ono H; Sato T; Otsuka Y; Yamada R; Ohshima T; Rino Y; Imada T
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1257-60. PubMed ID: 16969021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.
    Kim YH; Yamaguchi K; Bang YJ; Takiuchi H; Kang WK; Sato A; Kang YK; Sakamoto J; Abe C; Sakata Y
    Jpn J Clin Oncol; 2007 Jul; 37(7):501-8. PubMed ID: 17673470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients: efficacy and tolerability.
    Camps C; Caballero C; Blasco A; Safont MJ; Berrocal A; Garde J; Juarez A; Sirera R; Bremnes RM
    Anticancer Res; 2005; 25(6C):4611-4. PubMed ID: 16334151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status.
    Im CK; Rha SY; Jeung HC; Jeong J; Lee SH; Noh SH; Roh JK; Chung HC
    Oncology; 2009; 77(6):349-57. PubMed ID: 20016228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
    Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer].
    Makari Y; Fujiwara Y; Yasuda T; Takiguchi S; Kimura Y; Yano M; Monden M
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):609-11. PubMed ID: 15114710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of weekly administration of paclitaxel for advanced and metastatic gastric cancer].
    Emoto T; Yoshikawa K; Fujii M; Nezu R; Dousei T; Fujikawa M; Yoshioka Y; Naka Y; Komaki T
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):809-15. PubMed ID: 12852348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
    Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH
    Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma.
    Scott LC; Yao JC; Benson AB; Thomas AL; Falk S; Mena RR; Picus J; Wright J; Mulcahy MF; Ajani JA; Evans TR
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):363-70. PubMed ID: 18398613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases.
    Brambilla L; Romanelli A; Bellinvia M; Ferrucci S; Vinci M; Boneschi V; Miedico A; Tedeschi L
    Br J Dermatol; 2008 Jun; 158(6):1339-44. PubMed ID: 18363766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low-dose paclitaxel therapy as second-line chemotherapy for patients who previously received TS-1 therapy].
    Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2183-6. PubMed ID: 15628768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer.
    Yamamoto N; Tsurutani J; Yoshimura N; Asai G; Moriyama A; Nakagawa K; Kudoh S; Takada M; Minato Y; Fukuoka M
    Anticancer Res; 2006; 26(1B):777-81. PubMed ID: 16739353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.
    Lee KS; Chung HC; Im SA; Park YH; Kim CS; Kim SB; Rha SY; Lee MY; Ro J
    Breast Cancer Res Treat; 2008 Mar; 108(2):241-50. PubMed ID: 17476588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.